Pfizer opens biotechnological center in China

American pharmaceutical corporation Pfizer builds a biotechnological center in China. Company plans to put 350 million dollars in this project. Center will allow Pfizer to reach the huge Chinese medical market and helps increase sells. The main direction of the center will be medicaments, created from microorganisms, that will provoke a huge concurrence.

For the past 24 hours, Pfizer stocks increased on 2%. It is a great chance for traders to earn money. Trading will be available during American session, from 14:40 to 21:00 GMT time.

The news is only for informational purposes and cannot be construed as an offer or indication of the commission of certain transactions in the financial and commodity markets.